Tempus AI, Inc. (NASDAQ:TEM) CEO Sells $4,580,221.32 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 85,788 shares of the stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $53.39, for a total value of $4,580,221.32. Following the sale, the chief executive officer now directly owns 5,771,787 shares in the company, valued at $308,155,707.93. This represents a 1.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Tempus AI Stock Performance

NASDAQ TEM opened at $51.40 on Friday. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business’s fifty day moving average is $44.36 and its 200 day moving average is $47.59.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price for the company. Bank of America increased their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Guggenheim began coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $56.36.

Institutional Trading of Tempus AI

Hedge funds and other institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new position in shares of Tempus AI during the third quarter valued at $30,000. FNY Investment Advisers LLC acquired a new stake in Tempus AI in the fourth quarter valued at $67,000. Vestor Capital LLC bought a new position in Tempus AI during the 3rd quarter worth $153,000. Stifel Financial Corp acquired a new position in Tempus AI during the 3rd quarter worth about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $258,000. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.